Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Cadrenal Therapeutics Inc. Common Stock
CVKD | US
4.21
USD-0.23
-5.18%
CVKD | US
Loading StockChartView...
About Cadrenal Therapeutics Inc. Common Stock
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
08/06/2026
Close
4.21
Open
4.44
High
4.63
Low
4.15
Cadrenal Therapeutics Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was incorporated in 2022 and is headquartered in Ponte Vedra Florida.
View LessCVKD | US
Risk
63.2
Sharpe
-0.78
Luna's Score
39/100
Recommendation
Sell
Luna says (CVKD | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
60.5%1 month
63.2%3 months
95.1%6 months
106.8%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
5.11
Debt to equity
0.00
Debt to assets
0.00
Ent. to EBITDA
0.21
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-6.63M
MarketCap
4.98M
MarketCap(USD)
4.98M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-174.01
Short ratio
0.43
Short perc.
2.54
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
1.45
Range1M
2.17
Range3M
4.21
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.86
Price X volume
508.88K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.21 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 5.11 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 95.09 | 72.80 | Riskier |
| Debt to Equity | 0.00 | -1.23 | Expensive |
| Debt to Assets | 0.00 | 0.25 | Cheaper |
| Market Cap | 4.98M | 3.66B | Emerging |
